Pathology of idiopathic non-cirrhotic portal hypertension Masayoshi Kage Editorial 13 September 2017 Pages: 409 - 411
A brief review on prognostic models of primary biliary cholangitis Sha ChenWeijia DuanJidong Jia Review Article 14 September 2017 Pages: 412 - 418
Functional restoration of CD56bright NK cells facilitates immune control via IL-15 and NKG2D in patients under antiviral treatment for chronic hepatitis B Tao ChenLin ZhuQin Ning Original Article Open access 20 June 2017 Pages: 419 - 428
Risk of hepatitis B reactivation in HBsAg-negative/HBcAb-positive patients with undetectable serum HBV DNA after treatment with rituximab for lymphoma: a meta-analysis Zilin TangXiaodong LiJin Li Original Article 30 August 2017 Pages: 429 - 433
Ledipasvir/sofosbuvir without ribavirin is effective in the treatment of recurrent hepatitis C virus infection post-liver transplant Mohamed ShoreibahJordan OrrOmar Massoud Original Article 12 January 2017 Pages: 434 - 439
A cinnamon-derived procyanidin type A compound inhibits hepatitis C virus cell entry Catherine FauvelleMelanie LambotinChristiane Moog Original Article 11 July 2017 Pages: 440 - 445
Enhanced efficacy of radiofrequency ablation for hepatocellular carcinoma using a novel vascular disrupting agent, CKD-516 Su Jung HamYoonSeok ChoiKyung Won Kim Original Article 18 July 2017 Pages: 446 - 451
Prevalence of histological features of idiopathic noncirrhotic portal hypertension in general population: a retrospective study of incidental liver biopsies Chunlai ZuoVaibhav ChumbalkarHwajeong Lee Original Article 08 June 2017 Pages: 452 - 460
Liver failure determines the outcome in patients of acute-on-chronic liver failure (ACLF): comparison of APASL ACLF research consortium (AARC) and CLIF-SOFA models A. ChoudhuryA. JindalAPASL ACLF Working Party Original Article 30 August 2017 Pages: 461 - 471